(NASDAQ: SLGL) Sol Gel Technologies's forecast annual revenue growth rate of -72.22% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 36.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.88%.
Sol Gel Technologies's revenue in 2026 is $19,388,000.On average, 3 Wall Street analysts forecast SLGL's revenue for 2026 to be $15,006,247, with the lowest SLGL revenue forecast at $14,415,581, and the highest SLGL revenue forecast at $15,446,460.
In 2027, SLGL is forecast to generate $48,596,168 in revenue, with the lowest revenue forecast at $46,690,436 and the highest revenue forecast at $50,025,467.